# FADS6

## Overview
FADS6, or fatty acid desaturase 6, is a gene that encodes an enzyme involved in the biosynthesis of polyunsaturated fatty acids (PUFAs). The enzyme, also named fatty acid desaturase 6, is categorized as a desaturase and plays a critical role in the omega-6 and omega-3 fatty acid pathways by introducing double bonds into specific fatty acid substrates. This activity is essential for maintaining the balance of omega-6 and omega-3 PUFAs, which are crucial for various physiological processes, including membrane fluidity and cellular signaling. The enzyme is localized in the endoplasmic reticulum, where it contributes to lipid metabolism and homeostasis, impacting cellular proliferation, survival, and response to environmental changes (Zhao2023Investigating; Cui2022Molecular). FADS6 has been implicated in several health conditions, including cancer and neurodegenerative diseases, due to its role in lipid metabolism and its potential influence on inflammation and cellular signaling pathways (Raas2023Peroxisomal; Dogan2022Identification).

## Function
FADS6, or fatty acid desaturase 6, is an enzyme involved in the biosynthesis of polyunsaturated fatty acids (PUFAs) through the omega-6 and omega-3 pathways. It specifically desaturates linoleic acid (LA) to gamma-linolenic acid (GLA) and alpha-linolenic acid (ALA) to stearidonic acid (SDA), playing a crucial role in regulating the omega-6/omega-3 PUFA ratio, which is associated with physiological health (Cui2022Molecular). This enzyme is active in the endoplasmic reticulum, where it introduces double bonds into fatty acid chains, influencing membrane fluidity and signaling pathways (Zhao2023Investigating).

In healthy human cells, FADS6 is essential for maintaining normal fatty acid metabolism and homeostasis. Its activity is crucial for the regulation of lipid metabolism, which is significant for cellular processes such as proliferation, survival, and response to the cellular environment (Zhao2023Investigating). The enzyme's function in desaturating fatty acids is vital for maintaining cellular homeostasis and energy balance, contributing to the overall metabolic health of the organism (Cui2022Molecular). The specific role of FADS6 in healthy human cells, while not fully detailed, is inferred to be similar to its function in other organisms, focusing on lipid and fatty acid metabolism (Zhu2018Identification).

## Clinical Significance
FADS6 (fatty acid desaturase 6) is implicated in various diseases and conditions through its role in lipid metabolism. Alterations in FADS6 expression have been associated with breast cancer, where it is identified as a significant prognostic factor. Studies have shown that FADS6, along with other lipid droplet-associated genes, plays a role in the aggressiveness of breast cancer and may impact overall survival and metastatic transitions (Dogan2022Identification). Although FADS6 expression levels in breast cancer tissues are generally low, its involvement in fatty acid metabolism suggests a potential role in tumor progression (Zhao2023Investigating).

In the context of neurodegenerative diseases, FADS6 is part of a broader discussion on lipid metabolism alterations. While specific diseases directly linked to FADS6 mutations are not detailed, its role in the biosynthesis of polyunsaturated fatty acids may influence the production of signaling molecules involved in inflammation control, particularly in the brain (Raas2023Peroxisomal). This suggests that FADS6 could be relevant in conditions where lipid metabolism and inflammation are disrupted.


## References


[1. (Zhu2018Identification) Ke-Cheng Zhu, Ling Song, Hua-Yang Guo, Liang Guo, Nan Zhang, Bao-Suo Liu, Shi-Gui Jiang, and Dian-Chang Zhang. Identification of fatty acid desaturase 6 in golden pompano trachinotus ovatus (linnaeus 1758) and its regulation by the pparαb transcription factor. International Journal of Molecular Sciences, 20(1):23, December 2018. URL: http://dx.doi.org/10.3390/ijms20010023, doi:10.3390/ijms20010023. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20010023)

[2. (Zhao2023Investigating) Tingting Zhao, Pingping Gao, Yanling Li, Hao Tian, Dandan Ma, Na Sun, Ceshi Chen, Yi Zhang, and Xiaowei Qi. Investigating the role of fads family members in breast cancer based on bioinformatic analysis and experimental validation. Frontiers in Immunology, April 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1074242, doi:10.3389/fimmu.2023.1074242. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1074242)

[3. (Cui2022Molecular) Jie Cui, Haiqin Chen, Xin Tang, Hao Zhang, Yong Q. Chen, and Wei Chen. Molecular mechanism of interaction between fatty acid delta 6 desaturase and acyl-coa by computational prediction. AMB Express, June 2022. URL: http://dx.doi.org/10.1186/s13568-022-01410-0, doi:10.1186/s13568-022-01410-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13568-022-01410-0)

[4. (Raas2023Peroxisomal) Quentin Raas, Ali Tawbeh, Mounia Tahri-Joutey, Catherine Gondcaille, Céline Keime, Romain Kaiser, Doriane Trompier, Boubker Nasser, Valerio Leoni, Emma Bellanger, Maud Boussand, Yannick Hamon, Alexandre Benani, Francesca Di Cara, Caroline Truntzer, Mustapha Cherkaoui-Malki, Pierre Andreoletti, and Stéphane Savary. Peroxisomal defects in microglial cells induce a disease-associated microglial signature. Frontiers in Molecular Neuroscience, April 2023. URL: http://dx.doi.org/10.3389/fnmol.2023.1170313, doi:10.3389/fnmol.2023.1170313. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2023.1170313)

5. (Dogan2022Identification) Identification of lipid droplet-associated genes in breast cancer patients. This article has 1 citations.